The story of Sildenafil presents a nuanced case for investors in the pharmaceutical sector. While initially a tremendous success, generating huge profits, the patent expiration and the subsequent arrival of generic https://viagra264926.pointblog.net/the-little-copyright-and-big-pharma-a-risky-play-94312361